Matches in Nanopublications for { ?s ?p "[These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP625875.RAphgDARxZyJ0diWIGTYnYqqCxdVFCg52uJ6dPr-y00Gs130_assertion description "[These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625875.RAphgDARxZyJ0diWIGTYnYqqCxdVFCg52uJ6dPr-y00Gs130_provenance.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion description "[These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_provenance.